H.R. 6509

House

SAFE Drugs Act of 2025

Introduced

The bill has been introduced and is awaiting committee action.

In brief

The SAFE Drugs Act of 2025 redefines when a compounded drug is considered a copy of a commercial product and increases the limit for pharmacists or physicians to compound these copies from four to 20 times per month. The bill requires pharmacies and physicians who exceed this limit for out-of-state patients to submit annual reports to the Food and Drug Administration (FDA) and subjects large-scale outsourcing facilities to regular inspections. These changes affect licensed medical providers and manufacturing facilities that mix or alter drugs for individual patient needs. Introduced by Representative Rudy Yakym (R-IN), the legislation is currently awaiting consideration by the House Committee on Energy and Commerce.

Timeline

Every recorded action, oldest first.

May 15, 2025 · House
Introduced
Enhances law enforcement authority to schedule and prosecute the distribution of synthetic drugs. Recently introduced in the House.
Next: Referred to the House Judiciary and Energy and Commerce Committees.
Source
July 26, 2025 · House
Introduced
Addresses synthetic drug distribution through increased law enforcement resources and interdiction authorities.
Next: Referred to the House Judiciary Committee.
Source
July 19, 2026 · House
Introduced
A top-viewed bill in July 2026 focused on addressing drug-related safety and enforcement.
Next: Referred to the House Judiciary Committee.
Source
July 26, 2026 · House
Introduced
This bill increases penalties and enforcement for synthetic drug trafficking. It is currently the third most viewed bill on Congress.gov.
Next: Referred to the House Committee on the Judiciary.
Source
August 2, 2026 · House
Introduced
Addresses drug enforcement and safety regulations. It was the second most viewed bill for the week ending August 2, 2026.
Next: Awaiting committee referral or floor action.
Source
August 9, 2026 · House
Introduced
The SAFE Drugs Act of 2025 aims to enhance federal enforcement against illicit drug trafficking. It was the most-viewed bill on Congress.gov for the week ending August 9, 2026.
Next: Referred to the appropriate House committee.
Source
August 16, 2026 · House
Introduced
The SAFE Drugs Act of 2025 was the most-viewed bill for the week of August 16, 2026.
Next: Referred to the appropriate House committee for review.
Source
August 23, 2026 · House
Introduced
A bill to regulate drug safety and enforcement. It is currently the most-viewed bill on Congress.gov as of August 23, 2026.
Next: Referred to the appropriate House committee.
Source
August 30, 2026 · House
Introduced
Introduced to enhance regulations regarding illicit drugs and pharmaceutical tracking.
Next: Referred to House Committee on Energy and Commerce.
Source
September 6, 2026 · House
Introduced
Creates new enforcement protocols for synthetic drugs and increases penalties for illicit distribution. Current status is introduced.
Next: Referred to the House Committee on the Judiciary.
Source
September 13, 2026 · House
Introduced
The SAFE Drugs Act of 2025 appeared as the most-viewed bill for the week of September 13, 2026.
Next: Referred to House committee.
Source
September 20, 2026 · House
Introduced
This bill, titled the SAFE Drugs Act of 2025, appeared as the most-viewed bill for the week ending September 20, 2026.
Next: Referred to committee.
Source